Skip to search formSkip to main contentSkip to account menu

Endostar

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Effects of Combined Simultaneous and Sequential Endostar and Cisplatin Treatment in a Mice Model of Gastric Cancer Peritoneal Metastases
Objective. Aimed to study the effects of endostar and cisplatin using an in vivo imaging system (IVIS) in a model of peritoneal… 
2015
2015
Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial
PurposeEndostar is a recombinant human endostatin with antiangiogenic properties that has been useful in treating a wide range of… 
2015
2015
Endostar combined with irinotecan/calcium folinate/5-fluorouracil (FOLFIRI) for treating advanced colorectal cancer: A clinical study
Abstract Purpose: The current study aimed to evaluate the short-term efficacy and safety of endostar plus irinotecan/calcium… 
2014
2014
Antitumor effects of different administration sequences of cisplatin and Endostar on Lewis lung carcinoma
Angiogenesis plays an essential role in the growth and metastasis of a number of tumors. Anti-angiogenic drugs are able to… 
2012
2012
Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer
Standard chemotherapy for advanced NSCLC has reached a therapeutic plateau. More effective strategies must be explored. The… 
2012
2012
Synergistic Antitumor Effects of Endostar in Combination with Oxaliplatin via Inhibition of HIF and CXCR4 in the Colorectal Cell Line SW1116
Combination treatment with endostar, a novel modified endostatin, and cytotoxic chemotherapies showed a survival benefit in… 
2011
2011
Different combination schedules of gemcitabine with endostar affect antitumor efficacy
PurposeAntiangiogenic drugs inhibit tumor growth by decreasing blood supply and causing transient “normalization” of the tumor… 
2011
2011
[A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for…
OBJECTIVE To analyze the efficacy and quality of life and safety for paclitaxel and carboplatin (TC) and TC combined with… 
2010
2010
Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors.
PURPOSE Endostar is a proteolytic fragment of collagen XVIII that has been shown to have antitumor activity, with a favorable… 
2008
2008
Autophagic cell death of human hepatoma cells induced by endostar, a recombinant human endostatin.
AIM The aim of this study was to explore the contribution of different doses of Endostar (endostatin, YH-16) on autophagic death… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)